Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

Part of paid clinical trials in San Diego, California.

Sponsor
Scripps Whittier Diabetes Institute
Study ID
NCT06296550
Status
Recruiting
Apply to this trial

Conditions

  • Diabetes Type 2

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Dulce Digital Text Messaging Intervention — OTHER
    Text-based education support program: * Participants will receive text messages about diabetes and how to take care of diabetes and health. Participants will receive 2-3 messages every day for first 3 months, and then will slowly decrease over the last 3-months. * Participants will also receive text messages that will ask them to test their blood sugar and text back blood sugar reading.
  • CGM Device — OTHER
    Participants will be provided continuous glucose monitors (Dexcom G7) to actively monitor blood glucose for the entire duration of this study (i.e., one new device every 10 days for a total of 18 devices to last up to 6 months). In addition, participants will attend an information session (group or individual; in-person or virtual) that will provide instructions on using continuous glucose monitors.

Study Details

The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.

Key Dates

Start date
Apr 3, 2025
Status verified
Mar 2026
Primary completion
Apr 30, 2027
Completion
Apr 30, 2027

Study Design

Enrollment
140 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: CGM Group
    Participants will be provided continuous glucose monitors (Dexcom G7) to monitor blood glucose for the entire duration of this study (i.e., one new device every 10 days for a total of 18 devices to last up to 6 months).
  • Other: Usual Care Blood Glucose Monitoring Group
    Participants will use standard blood glucose monitoring devices that are covered by health insurance.

Primary Outcome Measure

HbA1c [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Scripps Whittier Diabetes InstituteSan DiegoCalifornia92037
Athena Philis-Tsimikas, MD
[email protected]
877-944-8843
Kallie Brown, PhD
[email protected]
858-258-3555

Find similar trials in San Diego, CA

By research site
Scripps Whittier Diabetes Institute· San Diego, CA

Related Studies